Adaptimmune Therapeutics ADAP reported its Q3 earnings results on Thursday, November 4, 2021 at 08:00 AM.
Here's what investors need to know about the announcement.
Adaptimmune Therapeutics their estimated earnings by 15.38%, reporting an EPS of $-0.3 versus an estimate of $-0.26, which surprised analysts.
Revenue was up $10,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0, which was followed by a 3.48% increase in the share price the next day.
Here's a look at Adaptimmune Therapeutics's past performance:
|Quarter||Q2 2021||Q1 2021||Q4 2020||Q3 2020|
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.